Manuela Berger

2.0k citations

24 papers · 857 indexed · h-index 16

Impact in

Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Drug-Induced Adverse Reactions
Gastroenterology top 5%

Papers in

Pharmacology 15
- Inflammatory mediators and NSAID effects 14
- Drug-Induced Adverse Reactions 3
Gastroenterology 2
- Gastroesophageal reflux and treatments 2

Co-authors: Jay L. Goldstein Fernando Laņas James M. Scheiman Francis K.L. Chan Há Thi Nguyen Bruce M. Hall NICHOLAS W. PEARCE Kay E. Gurley
Journals: The Journal of Rheumatology (2 papers)Immunobiology (2 papers)The American Journal of Gastroenterology (2 papers)Clinical Therapeutics (2 papers)Transplantation (2 papers)
Partner nations: United States Austria United Kingdom

In The Last Decade

Manuela Berger

22 papers receiving 816 citations

Peers

Countries citing papers authored by Manuela Berger

Since Specialization

Citations

This map shows the geographic impact of Manuela Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Berger more than expected).

Fields of papers citing papers by Manuela Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Berger. The network helps show where Manuela Berger may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Manuela Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manuela Berger Line = papers co-authored together Manuela Berger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Children’s International Polyposis (CHIP) study: a randomized, double-blind, placebo-controlled study of celecoxib in children with familial adenomatous polyposis Clinical and Experimental Gastroenterology ·Carol A. Burke, Robin Phillips, Manuela Berger, Chunming Li, Margaret Noyes Essex, RD Aradas, Patrick M. Lynch	2017	18
2	GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial The American Journal of Gastroenterology ·Byron Cryer, Chunming Li, Lee S. Simon, Gurkirpal Singh, Martin Stillman, Manuela Berger	2013	44
3	Safety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trials Expert Opinion on Drug Safety ·Margaret Noyes Essex, Richard Zhang, Manuela Berger, سارا دارابی, Peter W. Park	2013	32
4	Efficacy and Tolerability of Celecoxib in the Treatment of Acute Gouty Arthritis: A Randomized Controlled Trial The Journal of Rheumatology ·H. Ralph Schumacher, Manuela Berger, Julie Li‐Yu, Fernando Pérez-Ruiz, Rubén Burgos‐Vargas, Chunming Li	2012	43
5	GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial Arthritis Research & Therapy ·Byron Cryer, Chunming Li, Lee S. Simon, Gurkirpal Singh, Martin Stillman, Manuela Berger	2012	15
6	Efficacy of Low-Dose Celecoxib in Patients With Acute Pain Journal of Pain ·Bernard Schachtel, Dorothy McCabe, Manuela Berger, Richard Zhang, 小谷隆行, Vincent Gigot, 阿计, 高田淳子	2011	21
7	Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial The Lancet ·Francis K.L. Chan, Fernando Laņas, James M. Scheiman, Manuela Berger, Há Thi Nguyen, Jay L. Goldstein	2010	239
8	110 Celecoxib Versus Diclofenac and Omeprazole: A Randomized Controlled Trial Comparing a Composite Outcome Across the Entire GI Tract (The Condor Trial) Gastroenterology ·Francis K.L. Chan, James M. Scheiman, Ángel Lanas, Manuela Berger, Mark Li, Jay L. Goldstein	2010	0
9	A Novel Composite Endpoint to Evaluate the Gastrointestinal (GI) Effects of Nonsteroidal Antiinflammatory Drugs Through the Entire GI Tract The Journal of Rheumatology ·Francis K.L. Chan, Byron Cryer, Jay L. Goldstein, Fernando Laņas, David A. Peura, James M. Scheiman, Lee S. Simon, Gurkirpal Singh, Martin Stillman, C. Mel Wilcox, Manuela Berger, Aurora Breazna, William E. Dodge	2009	61
10	Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: A 12-week, multicenter, randomized, double-blind, placebo-controlled study Clinical Therapeutics ·Allan Gibofsky, 和人中田, Justus J. Fiechtner, Manuela Berger, Sharon Pan	2007	8
11	Endoscopic Ulcer Rates in Healthy Subjects Associated with Use of Aspirin (81 mg q.d.) Alone or Coadministered with Celecoxib or Naproxen: A randomized, 1-Week Trial Digestive Diseases and Sciences ·Jay L. Goldstein, James Aisenberg, Salam Zakko, Manuela Berger, William E. Dodge	2007	11
12	A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years Clinical Therapeutics ·Jay L. Goldstein, James Aisenberg, Frank L. Lanza, Howard Schwartz, George H. Sands, Manuela Berger, Sharon Pan	2006	18
13	Anti-CD4 Monoclonal Antibody-Induced Tolerance to MHC-Incompatible Cardiac Allografts Maintained by CD4+ Suppressor T Cells That Are Not Dependent upon IL-4 The Journal of Immunology ·Bruce M. Hall, P. Jaquet, Alain K. Zwave, Karren M. Plain, Rochelle Boyd, S. Timothy Spicer, Manuela Berger	1998	63
14	Obstructive Jaundice in Patients Receiving Hepatic Artery Infusional Chemotherapy: Etiology, Treatment Implications, and Complications after Transhepatic Biliary Drainage Journal of Vascular and Interventional Radiology ·Karen T. Brown, Nancy E. Kemeny, Manuela Berger, George I. Getrajdman, Brigitte L M Bauer, Yuman Fong, Sarkisian Bg, Robert C. Kurtz, José Botet, Leslie H. Blumgart	1997	13
15	INDUCTION OF LONG-TERM SPECIFIC TOLERANCE TO ALLOGRAFTS IN RATS BY THERAPY WITH AN ANTI-CD3-LIKE MONOCLONAL ANTIBODY Transplantation ·Mark R. Nicolls, Gregorio Aversa, NICHOLAS W. PEARCE, AUSTIN SPINELLI, Manuela Berger, Kay E. Gurley, Bruce M. Hall	1993	119
16	SPECIFIC UNRESPONSIVENESS IN RATS WITH PROLONGED CARDIAC ALLOGRAFT SURVIVAL AFTER TREATMENT WITH CYCLOSPORINE Transplantation ·NICHOLAS W. PEARCE, Manuela Berger, Kay E. Gurley, AUSTIN SPINELLI, Bruce M. Hall	1993	29
17	Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and Interleukin 2 Annals of Hematology ·Walter E. Aulitzky, Abudulajiang Nasier, 東京学芸大学化学科, W. Aulitzky, Manuela Berger, Rudi Reichenbächer, M. Herold, C Huber	1991	31
18	Recombinant tumour necrosis factor alpha administered subcutaneously or intramuscularly for treatment of advanced malignant disease: a phase I trial European Journal of Cancer and Clinical Oncology ·Walter E. Aulitzky, Herbert Tilg, Günther Gastl, Robert Mull, R. Flener, Wolfgang Vogel, Manfred Herold, Manuela Berger, G Judmaier, Christoph Huber	1991	18
19	Treatment of Cancer Patients with Recombinant Interferon-γ Induces Release of Endogenous Tumor Necrosis Factor-α Immunobiology ·Walter E. Aulitzky, Minour YOSHIMURA, J. Frick, Manfred Herold, Günther Gastl, Herbert Tilg, Manuela Berger, Christoph Huber	1990	10
20	Influence of Local Radiotherapy of Breast Cancer Patients on the Frequency of Cytotoxic T Lymphocyte Precursor Cells Immunobiology ·Manuela Berger, Eveline U. Irschick, Esther Fritsch, H Frommhold, D Schönitzer, ΑΝΔΡΕΑΣ ΧΡΙΣΤΟΔΟΥΛΙΔΗΣ, Georg Kemmler, Christoph Huber	1990	4

About Manuela Berger

Manuela Berger is a scholar working on Pharmacology, Gastroenterology, Immunology, Small Animals and Surgery, having authored 24 papers that have together received 857 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (14 papers), Helicobacter pylori-related gastroenterology studies (5 papers), Drug-Induced Adverse Reactions (3 papers), Immune Cell Function and Interaction (3 papers), Immune Response and Inflammation (3 papers), Synthesis of β-Lactam Compounds (3 papers), Neuropeptides and Animal Physiology (3 papers) and Gastroesophageal reflux and treatments (2 papers). The work is most often cited by research in Pharmacology (359 citations), Gastroenterology (68 citations), Immunology (220 citations), Transplantation (28 citations) and Rheumatology (128 citations). Manuela Berger has collaborated with scholars based in United States, Austria and United Kingdom. Frequent co-authors include Jay L. Goldstein, Fernando Laņas, James M. Scheiman, Francis K.L. Chan, Há Thi Nguyen, Bruce M. Hall, NICHOLAS W. PEARCE, Kay E. Gurley, Gregorio Aversa and Mark R. Nicolls. Their work appears in journals such as The Journal of Rheumatology, Immunobiology, The American Journal of Gastroenterology, Clinical Therapeutics and Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact